Breast cancer patients offered new hope from kidney drug (Daily Telegraph, 6 September 2008)

11 Sept 2008


A drug, sorafenib, currently used to treat cancer of the kidney has shown promise for breast cancer patients. Sorafenib reverses the effects of drug resistance, a common occurrence with current breast cancer treatments.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story